Sparc signs distribution agreement for graphene additive Sparc Technologies has executed a non-binding memorandum of understanding (MoU) with CLP Group subsidiary Chin Leong Construction Systems Pte Ltd. The parties will collaborate on marketing Sparc’s ecosparc additive to CLC’s coatings customers in Southeast Asia. Sparc Managing Director Nick O’Loughlin said: “Sparc…hopes to establish this partnership as…
Radiopharmaceutical medical imaging company Cyclopharm has received its first purchase orders from two United States Veterans Health Administration (VA) Hospitals – part of the largest integrated US Government health care system in the United States (US). The purchase orders for an initial five-year term apply to the installation and annual charges associated with the Technegas…
Radiopharmaceutical system manufacturer Cyclopharm has entered into an agreement to supply the Veterans Health Administration (VA), the largest US government health care system, with the pharmaceutical and consumable components of its Technegas imaging system. The Interim Agreement immediately provides the 120 Veterans Affairs hospitals, which have nuclear medicine departments, access to an agreed contract for…
Cyclopharm raises $20 million, seeks another $2 million Radiopharmaceutical imaging company Cyclopharm has successfully completed its institutional placement, raising $20 million before costs. The Placement attracted strong demand from both existing shareholders and from new institutional and sophisticated investors in Australia, Hong Kong, and the UK. A share purchase plan to raise up to $2.0…
Cyclopharm’s Technegas radiopharmaceutical imaging system has achieved a streamlined reimbursement approval process in the United States, boosting its prospects in what is the world’s largest market. The Sydney company has received a Coding Determination for Technegas from the Center for Medicare Medicaid Services (CMS), which means users will have a unique identifier which streamlines their…
DroneShield moves to profit on increasing global tensions Drone countermeasure company DroneShield has confirmed it moved to profit in FY23 on the back of rising global tensions and Russia’s invasion of Ukraine. The company reported record contracts and growing cash receipts which reached $73.5 million in FY23, five times the previous year. More than 68…
Radiopharmaceutical manufacturer Cyclopharm has announced unaudited FY23 revenue up 14 percent to $28.9 million and increasing momentum in the roll out of its Technegas lung imaging technology in the United States. The US launch has resulted in 80 issued contracts to date, covering more than 280 individual institutions, of which six are at the final…
Viraleze shows efficacy in Covid-19 patients – Starpharma Starpharma’s Viraleze antiviral nasal spray has demonstrated antiviral efficacy in a placebo-controlled study in participants with Covid-19. Viraleze achieved a statistically significant reduction in SARS-CoV-2 viral load, in the cohort of participants aged 45 and over. Viral load in the nose was reduced by 80 percent less…
Radiopharmaceutical manufacturer Cyclopharm has announced that Duke University Hospital in the United States has signed the first commercial contract for the use of its Technegas lung imaging system in the United States. Following the approval of Technegas by the United States Food and Drug Administration (USFDA) in September, this agreement signifies a major milestone for…
Radiopharmaceutical systems manufacturer Cyclopharm is expanding its manufacturing and storage capacity at Kingsgrove in Sydney to meet US demand, following approval by the USFDA for sale of the system in the big Uited States market. The Sydney company told investors it was preparing to air freight the first 20 Technegas systems to the USA, with…
